Theravance Biopharma (TBPH) Enterprise Value Growth (1y) (2015 - 2026)
Theravance Biopharma (TBPH) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Theravance Biopharma |
846.10 Mn |
451.44 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-201.61% |
| Dec 31, 2025 |
-92.63% |
| Sep 30, 2025 |
-93.91% |
| Jun 30, 2025 |
-252.63% |
| Mar 31, 2025 |
-30.89% |
| Dec 31, 2024 |
13.74% |
| Sep 30, 2024 |
31.82% |
| Jun 30, 2024 |
42.62% |
| Mar 31, 2024 |
58.56% |
| Dec 31, 2023 |
68.72% |
| Sep 30, 2023 |
72.47% |
| Jun 30, 2023 |
-26.05% |
| Mar 31, 2023 |
-63.55% |
| Dec 31, 2022 |
-88.79% |
| Sep 30, 2022 |
-125.16% |
| Jun 30, 2022 |
49.86% |
| Mar 31, 2022 |
29.74% |
| Dec 31, 2021 |
40.79% |
| Sep 30, 2021 |
39.66% |
| Jun 30, 2021 |
39.56% |
